IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2

The proinflammatory cytokine Interleukin 17A (hereafter named IL–17A) or IL-17A producing cells are elevated in breast tumors environment and correlate with poor prognosis. Increased IL-17A is associated with ER(−) or triple negative tumors and reduced Disease Free Survival. However, the pathophysio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cochaud, Stéphanie, Giustiniani, Jérôme, Thomas, Clémence, Laprevotte, Emilie, Garbar, Christian, Savoye, Aude-Marie, Curé, Hervé, Mascaux, Corinne, Alberici, Gilles, Bonnefoy, Nathalie, Eliaou, Jean-François, Bensussan, Armand, Bastid, Jeremy
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3856404/
https://ncbi.nlm.nih.gov/pubmed/24316750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep03456
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares